Taysha Gene Therapies Inc (TSHA)

08:05 AM

At $1.32 Price, Taysha Gene Therapies Inc (TSHA) Is Sitting And Waiting - stocksregister.com

08:05 AM

Mar 31, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 31, 2025

Mar 31, 2025

Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet - Benzinga

Mar 31, 2025

Mar 31, 2025

Taysha Stock Hits 52-Week Low at $1.17 Amid Challenges By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Taysha Stock Hits 52-Week Low at $1.17 Amid Challenges - Investing.com India

Mar 31, 2025

Mar 31, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World

Mar 31, 2025

Mar 26, 2025

Bank of New York Mellon Corp Acquires 111,989 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Mar 26, 2025

Mar 19, 2025

Is Taysha Gene Therapies (TSHA) the Best Short Squeeze Stock to Buy According to Analysts? - Insider Monkey

Mar 19, 2025

Mar 19, 2025

10 Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey

Mar 19, 2025

Mar 14, 2025

Analysts Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.63 - Defense World

Mar 14, 2025

Mar 13, 2025

Taysha Gene Therapies’ SWOT analysis: stock’s potential in Rett syndrome treatment By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 12, 2025

Taysha Gene Therapies’ SWOT analysis: stock’s potential in Rett syndrome treatment - Investing.com Australia

Mar 12, 2025

Mar 11, 2025

Taysha Gene Therapies (TSHA) to Release Earnings on Tuesday - Defense World

Mar 11, 2025

Mar 07, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 07, 2025

Mar 07, 2025

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks

Mar 07, 2025

Mar 07, 2025

Taysha's Latest Stock Option Grants: Key Details for Institutional Investors - StockTitan

Mar 07, 2025

Mar 03, 2025

TSHA FY2025 EPS Forecast Raised by Cantor Fitzgerald - Defense World

Mar 03, 2025

Mar 01, 2025

Needham & Company LLC Reaffirms Buy Rating for Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Mar 01, 2025

Feb 28, 2025

Chardan Capital Reiterates Buy Rating for Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Feb 28, 2025

Feb 27, 2025

Taysha Gene Therapies’ Positive Earnings Call Highlights - TipRanks

Feb 27, 2025

Feb 27, 2025

Positive Outlook for Taysha Gene Therapies: Buy Rating Backed by FDA Progress and Strong Financial Position - TipRanks

Feb 27, 2025

Feb 27, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2024 Earnings Call Transcript - MSN

Feb 27, 2025

Feb 27, 2025

Taysha Gene Therapies, Inc. (TSHA) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 27, 2025

Feb 27, 2025

Taysha Gene Therapies Reports 2024 Financial Results - TipRanks

Feb 27, 2025

Feb 26, 2025

Positive Outlook on Taysha Gene Therapies: Promising Developments and Financial Stability - TipRanks

Feb 26, 2025

Feb 26, 2025

Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Feb 26, 2025

Feb 26, 2025

Taysha Gene Therapies reports FY24 EPS (36c) vs (96c) last year - TipRanks

Feb 26, 2025

Feb 26, 2025

Taysha Gene Therapies Inc Reports Full Year 2024 EPS of -$0.36 a - GuruFocus.com

Feb 26, 2025

Feb 26, 2025

Earnings call transcript: Taysha Gene's Q4 2024 reports narrower loss, stock dips - Investing.com

Feb 26, 2025

Feb 26, 2025

Earnings call transcript: Taysha Gene’s Q4 2024 reports narrower loss, stock dips - Investing.com India

Feb 26, 2025

Feb 26, 2025

Taysha Gene Therapies, Inc. SEC 10-K Report - TradingView

Feb 26, 2025

Feb 26, 2025

Can Taysha's Gene Therapy for Rett Syndrome Deliver? Key Safety Milestone Reached as Cash Extends to 2026 - StockTitan

Feb 26, 2025

Feb 25, 2025

Taysha Gene Therapies Inc (TSHA) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Feb 25, 2025

Feb 21, 2025

Taysha Gene Therapies (TSHA) Projected to Post Earnings on Wednesday - Defense World

Feb 21, 2025

Feb 20, 2025

Taysha Gene Therapies to Release Full-Year 2024 Financial - GlobeNewswire

Feb 20, 2025

Feb 19, 2025

Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26 - The Manila Times

Feb 19, 2025

Feb 19, 2025

Gene Therapy Pioneer Taysha Readies Crucial 2024 Financial DisclosureHere's When - StockTitan

Feb 19, 2025

Feb 17, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Average Price Target from Brokerages - Defense World

Feb 17, 2025

Feb 15, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by SG Americas Securities LLC - Defense World

Feb 15, 2025

Feb 14, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 1.3%Time to Buy? - MarketBeat

Feb 14, 2025

Feb 14, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Feb 14, 2025

Feb 12, 2025

Critical Analysis: Creative Medical Technology (NASDAQ:CELZ) vs. Taysha Gene Therapies (NASDAQ:TSHA) - Defense World

Feb 12, 2025

Feb 07, 2025

Taysha Gene Therapies Inc (TSHA) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Feb 07, 2025

Feb 07, 2025

Taysha Gene Therapies Inc [TSHA] Records 50-Day SMA of $1.9835 - Knox Daily

Feb 07, 2025

Feb 07, 2025

Taysha's Strategic Move: 491K Stock Options Awarded to Secure Top Industry Talent - StockTitan

Feb 07, 2025